DBL EPIRUBICIN HYDROCHLORIDE INJECTION epirubicin hydrochloride 10mg/5mL injection vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

dbl epirubicin hydrochloride injection epirubicin hydrochloride 10mg/5ml injection vial

pfizer australia pty ltd - epirubicin hydrochloride -

Hospira Epirubicin Hydrochloride Injection 100 mg/50 mL vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira epirubicin hydrochloride injection 100 mg/50 ml vial

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - epirubicin hydrochloride is used in the treatment of: - breast, ovarian, stomach, lung and colorectal cancer - malignant lymphoma e.g. hodgkin's disease and non-hodgkin's lymphoma - multiple myeloma - non-invasive bladder cancer epirubicin is also used to help prevent recurrence of bladder cancer after surgery.

Hospira Epirubicin Hydrochloride Injection 50 mg/25 mL vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira epirubicin hydrochloride injection 50 mg/25 ml vial

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - epirubicin hydrochloride is used in the treatment of: - breast, ovarian, stomach, lung and colorectal cancer - malignant lymphoma e.g. hodgkin's disease and non-hodgkin's lymphoma - multiple myeloma - non-invasive bladder cancer epirubicin is also used to help prevent recurrence of bladder cancer after surgery.

Hospira Epirubicin Hydrochloride Injection 10 mg/5 mL vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira epirubicin hydrochloride injection 10 mg/5 ml vial

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - epirubicin hydrochloride is used in the treatment of: - breast, ovarian, stomach, lung and colorectal cancer - malignant lymphoma e.g. hodgkin's disease and non-hodgkin's lymphoma - multiple myeloma - non-invasive bladder cancer epirubicin is also used to help prevent recurrence of bladder cancer after surgery.

Hospira Epirubicin Hydrochloride Injection 200 mg/100 mL vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira epirubicin hydrochloride injection 200 mg/100 ml vial

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - epirubicin hydrochloride is used in the treatment of: - breast, ovarian, stomach, lung and colorectal cancer - malignant lymphoma e.g. hodgkin's disease and non-hodgkin's lymphoma - multiple myeloma - non-invasive bladder cancer epirubicin is also used to help prevent recurrence of bladder cancer after surgery.

Hospira Epirubicin Hydrochloride Injection 200 mg/100 mL vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira epirubicin hydrochloride injection 200 mg/100 ml vial

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - epirubicin hydrochloride injection is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.

EPIRUBICIN Irlanda - anglès - HPRA (Health Products Regulatory Authority)

epirubicin

seacross pharmaceuticals limited - epirubicin hydrochloride - solution for injection - 2 mg/ml - epirubicin

Epirubicin 2 mg/ml Solution for Injection Irlanda - anglès - HPRA (Health Products Regulatory Authority)

epirubicin 2 mg/ml solution for injection

seacross pharma (europe) limited - epirubicin hydrochloride - solution for injection - 2 milligram(s)/millilitre - anthracyclines and related substances; epirubicin

Hospira Epirubicin Hydrochloride Injection 50mg/25mL Hospira Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira epirubicin hydrochloride injection 50mg/25ml hospira

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - 1. relief of subjective and objective symptoms in the following diseases: acute leukaemia, malignant lymphoma, breast cancer, ovarian cancer, stomach cancer, liver cancer, urothelial cancer (bladder cancer, renal pelvic/ureteral cancer) 2. treatment of the following malignant cancer in conjunction with other anti-malignant cancer drugs: breast cancer (pre- and post-operative chemotherapy in operable cases)

Hospira Epirubicin Hydrochloride Injection 10 mg/5 mL single dose vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira epirubicin hydrochloride injection 10 mg/5 ml single dose vial

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - 1. relief of subjective and objective symptoms in the following diseases: acute leukaemia, malignant lymphoma, breast cancer, ovarian cancer, stomach cancer, liver cancer, urothelial cancer (bladder cancer, renal pelvic/ureteral cancer) 2. treatment of the following malignant cancer in conjunction with other anti-malignant cancer drugs: breast cancer (pre- and post-operative chemotherapy in operable cases)